Hybridomas secreting monoclonal antibodies to simian virus 5 (SV5) were obtained following immunization of mice with purified preparations of a human isolate (LN) of SV5. Immune precipitation studies showed that these monoclonal antibodies had specificities for the haemagglutinin-neuraminidase (HN), fusion (F), nucleo-, matrix and phospho-(P) proteins of SV5. By use of a radioimmune competition assay the monoclonal antibodies to the HN protein were assigned to four groups, members of which recognized different antigenic sites on the protein. All the anti-HN antibodies and the anti-F antibody neutralized virus infectivity. The 54 monoclonal antibodies obtained were used to determine whether there were antigenic differences between five human, two canine and one simian isolate of SV5. Although most of the monoclonal antibodies reacted with all isolates, a few did reveal antigenic differences in the HN, F and P proteins. Furthermore, analysis by SDS-PAGE showed that while the electrophoretic mobilities of most of the virus polypeptides of these isolates were similar some differences could be detected. In particular the P protein showed the most marked mobility differences between the human, canine and simian isolates. Slight differences in the mobility of the F1 glycoprotein could also be visualized.
INTRODUCTION
Simian virus 5 (SV5) has been isolated from the tissues of a number of animals including dogs, monkeys and humans. In dogs, SV5 commonly causes minor respiratory tract infections, although the virus has also been recovered from the cerebrospinal fluid of a dog v~ith temporary posterior paralysis (Baumgartner et al., 1981) . This particular isolate has subsequently been shown to cause experimentally induced encephalitis when inoculated into gnotobiotic dogs (Baumgartner et at., 1982) . Because SV5 commonly infects dogs the virus is usually referred to in veterinary circles as canine parainfluenza virus. However, SV5 was first isolated from rhesus monkey kidney cell cultures (Hull et al., 1956 ) and contamination of primary monkey cell lines with SV5 has been commonly encountered, presumably because monkeys may be persistently infected with the virus (Hsiung, 1972) . The origin of SV5 infections in monkeys is open to question (Hsiung, 1972) and it has been proposed that monkeys acquire infection via contact with humans after being brought into captivity (Tribe, 1966) . On a number of occasions the isolation of SV5 from human tissue has been reported (Hsiung, 1972; Robbins et al., 1981) , including on five separate occasions from the bone marrows of multiple sclerosis patients (Goswami et al., 1984; Mitchell et al., 1978) . Limited seroepidemiological studies have indicated that a reasonably high proportion (20 to 40~) of people have antibodies that react with SV5 (Hsiung, 1972; Goswami et al., 1984) . Although SV5 has not been associated with any acute human disease, recent evidence suggests that it may be involved in the aetiology of at least some cases of multiple sclerosis. The basis of this evidence is that a number of multiple sclerosis 0000-7868 © 1987 SGM METHODS Vero and BHK cells (Flow Laboratories) were grown as monolayers in 75 cm 2 tissue culture flasks or in rotating 80 oz Winchester bottles, in Dulbecco's modification of Earle's tissue culture medium containing 10~ newborn calf serum. Five human isolates of SV5 (designated LN, RQ, DN, NR, MT; Goswami et al., 1984) , two canine isolates (M7 and CPI-78-238; Cornwell et al., 1976 and Baumgartner et al., 1981, respectively ) and a prototype simian isolate (Pr; obtained from Central Public Health Laboratory, Colindale, London, U.K.) were grown and titrated under appropriate conditions in Vero cells using medium containing 2~ calf serum. All the virus isolates were plaque-purified and the virus stocks obtained were free from mycoplasma contamination. Furthermore, special emphasis was placed on obtaining virus stocks free from high levels of defective interfering particles. This was achieved by infecting the monolayers with approximately 0-1 p.f.u./cell and harvesting the virus present in the culture medium when the cells were showing between 70 and 80% c.p.e. All virus stocks were harvested before 30 h post-infection.
Cells and viruses.
Purification of virus. Monolayers of Veto cells in rotating Winchester bottles were infected with SV5 strain LN at an m.o.i, of 0.1 p.f.u./cell. When the cells showed 10 to 20~ c.p.e., the medium was decanted, the monolayer washed twice with warm phosphate-buffered saline (PBS) and the infected cells were reincubated at 37 °C in medium without calf serum until 80 ~ of the cells showed a c.p.e. (6 to 10 h later). The medium was then harvested and the small amount of cell debris present was pelleted by low speed centrifugation (I000~3 g for 15 min), followed by filtration through Whatman No. 1 filter paper. The virus was then pelleted by high speed centrifugation (70000g for 3 h),
Immunization of mice, production and selection of antibody-secreting hybridomas and nomenclature Jbr MAbs. Inbred BALB/c mice were immunized intraperitoneally with purified preparations of the SV5 isolate LN (250 gg of protein per immunization) precipitated on alum (Chase, 1967) . At the same time mice were immunized with a killed and fixed suspension of Bordetella pertussis (2 x 109 cells per mouse) to enhance the immune response (K6hler, 1981) . After 28 days, mice were reimmunized intraperitoneally with virus only, and after a further 21 days they were boosted by both an intraperitoneal and a tail vein immunization. Four days later their spleens were removed, the splenocytes were fused with SP2/0-Ag-14 myeloma cells (Shulman et al., 1978) and the hybrid cells were plated in 96-well microtitre plates so that approximately one colony of ceils grew in every other well under selective growth conditions. Cell culture conditions were based on those previously described (Fazekas de St. Groth & Scheidegger, 1980; K6hler & Milstein, 1975) . Hybridomas secreting antibodies specific for virus antigens were differentiated from those secreting antibody to uninfected cell antigens using a method in which infected or uninfected cell antigens were bound to sheets of nitrocellulose, media from hybridoma cells were then incubated with the nitrocellulose sheets, and bound antibody was identified using 12Si_labelled Protein A or with peroxidaseconjugated anti-mouse immunoglobulin. Full details of the technique have been published elsewhere, as have the methods for subcloning hybridomas secreting specific antibody to virus antigens and for the production of ascitic fluids (Randall et al., 1984) . Each MAb was originally given a laboratory number corresponding to the hybridoma colony tested. Subsequently when the reactivity of the MAbs had been established, they were given a capital letter After an adsorption period of 2 h at 37 °C, the inoculum was removed and replaced with tissue culture medium containing 2 ~ newborn calf serum. When the cells showed a 10 to 20 ~ c.p.e, they were radioactively labelled for 4 to 6 h with L-[3sS]methionine (500 Ci/mmol; Amersham) in tissue culture medium containing one-tenth the normal concentration of methionine (i.e. 1.5 mg/1). At the end of the labelling intervals, the cells were washed in ice-cold PBS and lysed into immune precipitation buffer [10 mm-Tris HC1 pH 7-2, 5 mM-EDTA, 0-5~ NP40, 0.65 M-NaC1 and in some experiments 0-1 ~ SDS (see text); 4 × 106 to 10 × 106 cells per ml of buffer] by sonication with an ultrasonic probe. Soluble antigen extracts were obtained after pelleting the particulate material from these total cell antigen extracts by centrifugation at 400000 g for 30 min. Immune complexes were formed by incubating 0-2 ml samples of the soluble antigen fraction with an excess of antibody (1 ~tl of undiluted ascitic fluid) for 2 h at 4 °C. If the antibody involved bound directly to Protein A the immune complexes were isolated on an excess of a fixed suspension (Kessler, 1975) of the Cowan A strain of Staphylococcus aureus (20 ~tl of a 10~ w/v suspension per ~tl of ascitic fluid for 30 min at 4 °C). If the MAbs did not bind Protein A directly, these immune complexes were isolated in an identical manner, except preparations of fixed S. aureus that had been previously saturated with sheep anti-mouse immunoglobulin (SAPU, Carluke, U.K.) were used (50 p.l per ~tl of ascitic fluid). This latter method is an extremely simple method for precipitating MAbs that do not bind Protein A directly. The immune complexes on S. aureus were washed three times by suspension and sedimentation (2500 g for 3 min) from immune precipitation buffer containing 10~ sucrose. The proteins in the immune complexes were dissociated by heating (80 °C for 5 min) in gel electrophoresis sample buffer (0-05 M-Tris-HCI pH 7-0, 0-2~ SDS, 5~o 2-mercaptoethanol and 5~ glycerol), and analysed by SDS-PAGE. After electrophoresis, gels were either stained with Coomassie Brilliant Blue and destained in acetic acid methanol or were stained using the Bio-Rad silver staining kit (total protein stain) and dried. Labelled polypeptides were visualized by autoradiography with Fuji X-ray film.
Radioimmune competition assay. Monoclonal antibodies were purified on a Protein A-Sepharose column (Goswami & Russell, 1983 ) and radioactively labelled with 1:5I using the chloramine-T method (Hunter, 1978) . Iodinated MAbs were titrated against infected cell antigen bound to nitrocellulose using an assay that has been described elsewhere (Randall et al., 1984) with the modification that the nitrocellulose sheet was sandwiched between 84-well Teraski plates (10 gl of diluted antibody per well). Unlabelled MAbs were then tested for their ability to compete with the binding of the 125I-labelled antibodies by making fourfold dilutions of ascitic fluids (starting at a 1/20 dilution) in an appropriate dilution of the 12Si_labelled antibody in PBS containing 1 ~ bovine serum albumin. The antibodies were then reacted with virus antigens bound to nitrocellulose sheets as described.
Assay to ascertain the reactivity of MAbs to various isolates of SV5. Vero cells, grown as monolayers in 96-well microtitre plates, were infected with the different isolates of SV5. When the cells showed an 80~ c.p.e. (24 to 30 h post-infection) the cells were fixed in 5~ formol-saline, 2~o sucrose in PBS for 10 min at 20 °C. The monolayers were then washed three times with PBS, permeabilized with 0.5~ NP40, 10~ sucrose in PBS for 5 min at 20 °C and washed three times in PBS containing 1 ~ calf serum. The monolayers were reacted for 1 h at 20 °C with MAbs (as ascitic fluid diluted 1/500 in PBS). The monolayers were washed tour times with PBS containing 1 o/calf serum and incubated for 1 h with 125I-labelled Protein A (Amersham). If the MAb did not bind Protein A directly the washed monolayer was first treated for 1 h at 20 °C with rabbit anti-mouse immunoglobulin (diluted 1/10000 in PBS; Nordic Immunological Laboratories, Maidenhead, U.K.) and washed four times with PBS containing 1 calf serum before the addition of 125I-labelled Protein A. The monolayers were then washed once with PBS containing 0.1 ~ NP40 and three times with PBS, dried and exposed to Fuji X-ray film with an intensifying screen at -70 °C.
Neutralization test. One-hundred ~tl amounts of twofold dilutions of MAbs (as ascitic fluids diluted in tissue culture medium containing 2~ calf serum) were incubated at 37 °C for 2 h with 100 I-tl of the SV5 isolate LN (1 x l0 s p.f.u./ml). The antibody virus mixtures were then used to infect Veto cells growing as monolayers in 96-well microtitre plates. After a 2 to 4 h adsorption period the virus antibody inoculum was replaced with tissue culture medium containing 2~ calf serum and the cells were reincubated at 37 °C for a further 3 to 4 days, when they were fixed with formol saline, stained with crystal violet and the c.p.e, endpoint was determined. 7) and M (lane 6) polypeptides. The buffer used to prepare the soluble antigen extract for the immune precipitates shown in lanes 1 to 6 contained both 0.1 ~ SDS and 0.5~ NP40 as detergents, whereas that used for lane 7 contained 0-1 NP40 as the sole detergent.
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RESULTS

Isolation and characterization of MAbs
Purified preparations of an SV5 derived from a human isolate (LN) were used to immunize BALB/c mice for the production of hybridoma cells. The virus was purified as described in Methods. SDS-PAGE analysis revealed that more than 70~o of the proteins present in these virus preparations were of virus origin (Fig. 1) . Fifty-four hybridoma cell lines were established that secreted MAbs to SV5. The specificities of these MAbs were determined by immune precipitation (Fig. 2) . Of these MAbs, 17 reacted with the HN glycoprotein, one with the F glycoprotein and 22, 11 and three with the M, P and NP proteins respectively. The MAb to the F protein precipitated both the precursor F0 polypeptide and its processed form, which dissociates into two polypeptides F1 and F2 under the reducing conditions used for SDS-PAGE. 
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Monoclonal antibodies to the P protein immune-precipitated complexes of the P, N and L proteins from the standard soluble antigen extracts of SV5-infected cells (i.e. in which 0 . 5~ NP40 was the only detergent). However, the addition of 0.1 ~ SDS to the soluble antigen extract resulted in the NP protein being released from these complexes ( Fig. 2 ; compare lanes 5 and 7).
To dissociate the P and L proteins a higher concentration of SDS (0.5 ~) was required (Fig. 3) . If the soluble antigen extracts were made from SV5-infected BHK cells a number of extra bands were specifically precipitated by MAbs to the P protein in the absence of noticeable proteolysis of other virus proteins. However, if the soluble antigen extract was made from SV5-infected Vero cells, these antibodies precipitated the P protein and only one extra polypeptide, with an estimated mol. wt. of 24000 (compare Fig. 2 and 3 ).
Evidence that MAbs bind to different antigenic sites on the H N protein
The MAbs that reacted with the HN protein were examined for their ability to neutralize virus infectivity. The results, summarized in Hn-I a and Hn-2a are MAbs H N-1 and HN-2 respectively previously isolated by Goswami & Russell (1983) . H N-2a was not available for these tests but has been included to take into account that nomenclature.
Summary of properties of MAbs
:~ Weak binding to Protein A. § Not determineC [I Anti-HN MAbs that do not prevent binding of any other MAb but have not been labelled with ~25I themselves for use in competition tests.
whether anti-HN antibodies bound to different regions of the HN protein by a radioimmune competition assay (Fig. 4) . By this method the anti-HN antibodies were placed into different groups, antibodies within a group showing some competitive binding with at least one other member of the group, but failing to compete with the binding of any antibody in another group. The MAbs were given specific names (see Methods), instead of their original trivial laboratory ones, once their reactions in these competitive assays had been established (Fig. 4) . The region of the HN protein recognized by one group of antibodies we defined as an antigenic site. These antigenic sites could be divided into smaller overlapping immunogenic regions called epitopes that were defined as the minimum region of the HN protein required for the binding of an antibody. Thus, MAbs which bound to the same antigenic site may not recognize the same epitope within that site. For example, the MAbs HN-4c and HN-4a competed poorly with the binding of lzSI-labelled HN-4b while in the same test the unlabelled HN-4b was an efficient competitor (Fig. 4) . In contrast, HN-4a was the most efficient antibody in competing with the binding of 12SI-labelled HN-4a, while HN-4b was an extremely poor competitor (data not shown). Furthermore, HN-4d, HN-4e and HN-4f all successfully competed with the binding of HN-4a (data not shown) but not HN-4b (Fig. 4) . However, because HN-4a and HN-4b showed some competitive binding they have been placed in the same group of antibodies. Not all the MAbs were purified and labelled with 125I for use in the competition assay. If an unlabelled antibody competed with the binding of an 12SI-labelled antibody then both antibodies were placed in the same group and a reciprocal analysis was not usually carried out. A summary of the competition results is given in Table 1 . However, it should be noted that as well as competition between the binding of antibodies to the HN protein it also appeared that the binding of one antibody could enhance the binding of another antibody; for instance compare the intensity of binding of 125I-labelled HN-4b in the presence of HN-5a to that in the presence of HN-3a (Fig. 4) .
Studies on the differences between human, monkey and canine isolates of SV5
Five human isolates (LN, RQ, NR, MT and DN), a simian isolate (Pr) and two canine isolates (M7 and CPI) of SV5 were analysed by SDS-PAGE for differences in the electrophoretic mobilities of their proteins. Fig. 5(a) shows an analysis of the immune precipitates formed following the reaction of a mouse polyclonal anti-SV5 serum with labelled soluble antigen extracts of BHK cells infected with the different isolates of SV5. While the electrophoretic patterns of most of the virus polypeptides of the different isolates were similar, clear differences in the electrophoretic migrations of some polypeptides could be seen. In particular, the P polypeptide of M7 migrated slightly slower than that of the human isolates and these in turn migrated slower than the P polypeptide of the simian isolate (Fig. 5b) . Slight differences in the migration of the F1 polypeptide could also be seen. For example, the F~ protein of SV5 human isolate NR migrated faster than the F 1 protein from all the other isolates (Fig. 5a , see also Fig. 8) .
The various SV5 isolates were also tested for their ability to react with the MAbs to SV5. Several screening procedures were used including immunofluorescence, radioimmune assay using SV5 antigens bound to nitrocellulose (as used for screening hybridomas secreting antibody to SV5; see Methods) and a radioimmune assay in which the MAbs were reacted with virusinfected cells grown in 96-well microtitre plates that had been fixed and permeabilized as for immunofluorescence. It was found that this latter test was the most convenient and an example of such a test is shown in Fig. 6 . The majority of MAbs reacted with all the isolates, but a number of antibodies revealed antigenic differences between the human, simian and canine isolates examined. Thus, for example HN-3a reacted with all the human and canine isolates examined but failed to react with the simian isolate (see below); HN-4b and HN-z failed to react with either of the canine isolates but did react with the human and simian isolates (Fig. 6 , rows a, wells 7 and 8); F-la reacted with the human and simian isolates but failed to react with the canine isolates (Fig. 6, rows d, well 4) and three MAbs, Pa, Pd and Ph, to the P protein could distinguish between the human, canine and simian isolates of SV5 (e.g. Fig. 6 , rows c, wells 1,4 and 6). However using this assay no differences in the reactivities of any of the MAbs with the human . The polypeptides present in the immune precipitates were separated by electrophoresis through a 15% SDS polyacrylamide gel. The soluble antigen extracts used in the immune precipitation reactions contained both 0-5% NP40 and 0.1 ~ SDS as detergents. Lanes 1, canine isolate M7; lanes 2, simian isolate Pr; lanes 3 to 7, human isolates DN, LN, NR, MT, RQ, respectively.
isolates of SV5 were observed. Furthermore, no MAb was identified that could distinguish between the two canine isolates. Confirmation that certain antibodies reacted with some of the SV5 isolates but not others was obtained by immune precipitation and two such results are shown in Fig. 7 and 8. It can be seen from Fig. 7 that HN-3a failed to react with the HN protein of the simian isolate whereas HN-4a reacted with the HN protein of all the isolates examined. In contrast, it can be seen from Fig. 8 that F-la reacted with the human and simian isolates but not with the canine (M7) isolate. A summary of the characteristics of the MAbs and their reactivities with the different SV5 isolates is given in Table 1 .
DISCUSSION
In this paper we report the isolation and characterization of MAbs to SV5. Virus for the immunization of mice was purified by the rapid and simple technique described in Methods. Although the addition of medium without calf serum and its time of harvesting is critical, the yield and purity of the preparations we obtained using this method (Fig. 1) were routinely better than when we followed the method described previously (Goswami & Russell, 1982 ; data not shown).
Monoclonal antibodies were isolated which had specificities to the HN, F, P, M and NP proteins of SV5. The MAbs to the P protein were of interest in that they immune-precipitated nucleoprotein complexes, consisting of the P, NP and L proteins, from soluble antigen extracts of SV5-infected cells in which NP40 was the only detergent. Antibodies to the NP also precipitated some P and L proteins from similar soluble antigen preparations although the ratio of NP to P protein precipitated was approximately 10 to 1 (data not shown) compared to 1 : 2 that was precipitated by anti-P MAbs. This was presumably because, of the uncomplexed proteins in the soluble antigen extract, there was more NP than P protein. The NP protein was released from the complexes by treatment with 0.1 ?/o SDS but higher concentrations of SDS were required to dissociate the P and L proteins (Fig. 3) . The origin of the minor bands precipitated Table 1 . by anti-P antibodies from soluble antigen preparations of BHK cells is unclear. Differences in the electrophoretic mobilities of these minor polypeptides between the human and monkey isolates were observed, and these reflected similar differences in the electrophoretic mobilities of the P protein of these isolates, suggesting that these minor polypeptides are related to the P protein (data not shown). It is unlikely that they represent breakdown products of the P protein as no proteolysis of the other virus proteins was seen. Furthermore, virus proteins, in particular the NP and M proteins, in Vero cell lysates are much more sensitive to proteolysis than in BHK cell lysates (R. E. Randall et al., unpublished observations) and a similar array of P-related bands in Vero cell lysates have not been seen. Paterson et at. (1984) and R. A. Lamb (personal communication) came to the conclusion that polypeptide V (Fig. 3) is synthesized by translation beginning at a second downstream initiation site on the P m R N A in the same reading frame as P. It might therefore be that the multiple bands precipitated by anti-P antibodies from BHK lysates reflect the use of multiple internal initiation sites on the P m R N A some of which are not utilized in Vero or CV-1 cells. Anti-HN antibodies were used to define at least four different antigenic sites on the H N glycoprotein; antibodies to all these sites neutralized virus infectivity. It is clear that not all the MAbs that react with one antigenic site recognize the same epitopes within that site. For example, although HN-4a and HN-4b showed some competitive binding with one another and thus were placed in the same group of antibodies, homologous competitive binding of these antibodies was much stronger than heterologous competitive binding. Furthermore, HN-4a reacted with all the SV5 isolates examined, whereas HN-4b failed to react with the canine isolates. There is, however, another possible explanation for these results. It may be that HN-4a and HN-4b recognize distinct antigenic sites but that the binding of an antibody to one site alters the conformation of the HN protein so as to weaken the binding of an antibody at another site. The reverse may also be true. In the competition assays it was noted that some MAbs appeared to enhance the binding of 125I-labelled antibodies (Fig. 4) . This positive cooperative binding may be significant with regard to how polyclonal antisera interact with proteins. We have used these MAbs to examine antigenic differences between human, canine and simian isolates of SV5. The radioimmune assay we found to be most convenient relied upon the interaction of the MAbs with infected monolayers in 96-well microtitre plates (Fig. 6) . It is interesting to note that although this assay was not employed to screen for hybridomas secreting antibodies to SV5, no antibody was isolated that did not react in this assay. Using it we failed to detect any antigenic differences between the human isolates of SV5, although we did note small variations in the electrophoretic mobility of the F1 polypeptide ( Fig. 5 and 8) . However, minor differences between human isolates have been reported previously, based mainly on the efficiency of neutralization of the RQ and LN isolates by specific antisera, including H N -l a (Goswami et al., 1984 ). An analysis of more human isolates and from different geographical regions (all the human isolates of SV5 used in this study were isolated in London) needs to be carried out in order to determine whether the degree of antigenic variation among human isolates of SV5 is less than that reported for other paramyxoviruses such as mumps, parainfluenza type 3, respiratory syncytial and measles viruses (Norrby, 1985; Rydbeck et al., 1986; Van Wyke Coelingh et al., 1985; Mufson et al., 1985 ; Sheshberadaran et al., 1983) . In this context however, it should be noted that in contrast to comparisons between human and bovine parainfluenza virus type 3 (Ray & Compans, 1986 ) there appears to be a very high degree of antigenic conservation between the human, canine and simian isolates of SV5 with the majority of MAbs reacting with all of the isolates examined. We did identify small antigenic differences between the HN, F and P proteins of the human, canine and simian isolates, athough none of the MAbs to the M protein distinguished these isolates. Thus, as has been reported for parainfluenza virus type 3 (Galinski et al., 1987) , the M protein may be the most evolutionarily conserved virus protein. The electrophoretic mobility of the P protein varied between the human, canine and simian isolates of SV5 as determined by SDS-PAGE. While in this study we examined only a few SV5 isolates, it is of interest to note that the reactivity of the MAbs to the two canine isolates M7 and CPI were the same even though these viruses were isolated originally in the U.K. and U.S.A. respectively. Other researchers have also noted small antigenic differences between canine isolates and human and simian isolates (Lazar et al., 1970) . Whether the differences between the human, canine and simian isolates of SV5 are sufficient to restrict virus transmission between species or whether different SV5 isolates regularly cross species barriers remains to be established. However, such studies will be of obvious importance if the observation that SV5 plays a role in the aetiology of some cases of multiple sclerosis (Goswami et al., 1987) can be substantiated.
